News Archive

ROCKVILLE, Md., Sept. 23, 2020 /PRNewswire/ — Cellphire, the global leader in long-term stabilization and storage of platelets, is proud to announce that the Armed Services Blood Program (ASBP) has awarded Cellphire President G. Michael Fitzpatrick, PhD, with the 2020 ASBP Lifetime Achievement Award for his service and significant contributions to ASBP and the warfighter.

ROCKVILLE, Md., Sept. 23, 2020 /PRNewswire/ — Emmes today announced that Dr. Christine Dingivan has joined the company as its new president and chief executive officer.  She is succeeding Dr. Anne Lindblad, who is retiring after 38 years at the company.  Dr. Dingivan will be Emmes’ fourth chief executive since the company was founded in 1977.

Image: https://www.biospace.com

Unlike some other manufacturers, Samsung Biologics has enjoyed a revenue boost from the novel coronavirus pandemic, and it’s accelerating its expansion plans to match. With a $2 billion “super plant” in the offing, Samsung now has a new Big Pharma supply deal in place to keep driving growth.

AstraZeneca tapped Samsung Biologics for a $331 million supply pact to produce bulk drug substance and “drug product to support AstraZeneca’s biologics therapeutics” at the CMO’s Plant 3 facility in Incheon, South Korea, the partners said Tuesday.

Image: Samsung Biologics’ expansion plans include a $2 billion “super plant” at the CMO’s Incheon complex. (Samsung)

BALTIMORE (WJZ) — TIME recently named a Johns Hopkins University professor to its 2020 list of the 100 most influential people in the world for developing a free and open website for the public to track the COVID-19 pandemic in near-real-time.

Lauren Gardner, a civil and systems engineering professor in the Whiting School of Engineering, led the team that built the COVID-19 Dashboard in late January.

Image: https://coronavirus.jhu.edu/map.html

GREENVILLE, S.C. – Allen Burgenson had a job, his father explained as they stood on the sand.

This was Allen’s first fishing trip, but he wasn’t going to take anything from the bay. He was to return the water’s gifts to the deep, where they’d belonged for hundreds of millions of years. 

If he spotted a horseshoe crab on its back, his father said as he held Allen’s hand, that meant it was in trouble and needed Allen’s help to get home. Allen just had to flip it over. Its 10 legs could make it the rest of the way back to the crashing waves. 

Image: https://www.usatoday.com

CRCHD seeks motivated scientists to serve as Program Directors in its Diversity Training Branch (DTB) and Integrated Networks Branch (INB). These Program Directors will manage and develop a portfolio of innovative grant-supported diversity training (DTB) and network-based initiatives (INB), and identify scientific opportunities to generate new knowledge supporting the NCI mission. The successful candidates will hold a Ph.D., M.D. or equivalent degree.

BioHealthInnovation invites you to join over 120 leading VCs, Corp VCs, Angel Investors and over 100
Top Innovators online at Venture Summit Virtual Connect being held on November 17th – 19 th 2020.
One-on-One (zoom) investor meetings, 2 days of content including timely panel discussions, workshops
and an inspiring keynotes. Register now to confirm your spot: https://bit.ly/2DMyzYx & get an extra
20% off the Early Bird Rates with Discount Code: BIOHEALTHVIP .

Listen now via Apple https://apple.co/2RMiuoY, Google https://bit.ly/3iUXZCw, Spotify https://spoti.fi/32R5ll4, TuneIn https://bit.ly/33QE1m0, YouTube (Audio) https://bit.ly/367Ux47.

Dr. Mossman obtained her Ph.D. in herpes virology from the University of Liverpool, UK. Thereafter she conducted two postdoctoral fellowships in HIV vaccine research in the USA, first at Colorado State University, Fort Collins, and then at the University of Washington, Seattle. She spent 8 years within Corixa Corporation, a biotechnology company focusing on developing novel approaches to vaccines, including adjuvants, delivery strategies, and proprietary antigen candidates for infectious disease and cancer vaccines.  She joined GlaxoSmithKline Vaccines in 2006 and spent 10 years in Rixensart Belgium in the early development of infectious disease vaccines. More recently, she relocated to Maryland as part of the founding leadership team for the USA R&D headquarters for GSK Vaccines in Rockville, where she was initially heading up the Discovery effort. She is now Head of the Rockville R&D site and oversees a portfolio of vaccine candidates at all stages of development as well as driving key vaccine technologies, including mRNA and Adenovirus platforms.